Cancer Performance MDT Validator | North Middlesex University Hospital NHS Trust

This is a 6-month job opportunity funded by the Cancer Alliance. The role is critical in improving the accuracy and timeliness of tracking oncology treatment pathways, ensuring that patients receive necessary interventions promptly, and supporting the hospital in meeting national cancer performance targets, particularly the 62-day standard. The role involves facilitating the development, management, and administration of the weekly NMUH cancer multidisciplinary team (MDT) meetings. It is a national cancer standard that all new cases are discussed in a weekly MDT meeting to agree on a management plan.

• Collaborate with cancer services managers and key stakeholders, including cancer site lead consultants, surgeons, histopathologists, radiologists, cancer nurse specialists, physicians, oncologists, medical secretaries, admissions, medical records, and X-ray library.
• Facilitate and administer the weekly cancer MDT meetings.
• Ensure effective tracking of patient oncology pathways, with a focus on meeting national cancer performance standards. This role is essential in streamlining cancer treatment coordination and ensuring that patients are not subject to delays in their treatment plans.
• To ensure that the data for the NHS National Waiting Times Standards for the 14, 31 and 62 day targets is collected, monitored and performance managed prospectively for reporting on a weekly basis; liaising with MDT membership and the cancer managers to ensure compliance with the targets. The cancer targets are in line with national and Trust corporate objectives.
North Mid is part of North Central London integrated care system - consisting of the NHS and Local authority organisations in Camden, Islington, Barnet, Enfield and Haringey. As with other ICS's, we are working increasingly closely with partners and indeed many of our financial and performance objectives are measured at this system level. Whilst all organisations remain as standalone, statutory bodies we have an ICS infrastructure for making shared decisions and agreeing shared approaches. We are proud of our staff and want to ensure their training allows them to provide excellent clinical care. We are also a training unit for medical students from UCL and St George's University Grenada, and for nursing and midwifery students from Middlesex and City Universities. Take a tour of our hospitalhere Ensuring Accurate, Real-Time Tracking, the MDTC will be responsible for maintaining real-time updates of the 31-day Patient Tracking List (PTL), allowing for the timely identification of patients requiring urgent intervention. Timely Escalations By monitoring patient pathways closely, the MDTC will ensure that any delays are promptly escalated to the appropriate clinical teams, facilitating faster decision-making and reducing the likelihood of treatment delays. Improving 62-Day Performance,through diligent management of the cancer pathways, the MDTC will play a pivotal role in improving NMUH's compliance with the 62-day standard, thereby enhancing patient outcomes and aligning the hospital's performance with national benchmarks. Supporting Early ITRs ,the MDTC will streamline the process for initiating treatment requests, ensuring that patients are registered on the cancer pathway at the earliest opportunity. Providing a Safety Net for Subsequent Cancer Patients,the role will include tracking and supporting patients who are further along in their treatment journey, ensuring continuous care and minimizing the risk of patients being overlooked.